This plasmid was mobilized by a triparental mating to the wild-type strain 1021 for replacement of the hfq gene by the modified allele. Four out of the 18 colonies screened by colony PCR

after the second cross-over event were found this website to incorporate the 3 × FLAG coding sequence and were kept for further Western analysis with commercial FLAG antibodies (Sigma-Aldrich). All plasmid constructs requiring previous PCR amplification of the cloned inserts were checked by sequencing. The correct genomic arrangements in all the S. meliloti hfq derivative strains were assessed by Southern hybridization of genomic DNA with the appropriate radioactive labeled dsDNA probes using standard protocols. Transcriptomics Total rhizobial RNA was purified from log cultures in TY broth (10 ml)

using the RNeasy Mini Kit (Qiagen, Hilden, Germany) following manufacturers instructions. Cy3- and Cy5-labeled cDNAs were prepared from 20 μg total RNA according to an amino-allyl dye coupling protocol as previously described [66, 67]. Two slide (Sm14KOLI microarrays) hybridizations were performed with labeled cDNA from RNA preparations corresponding to 3 independent bacterial cultures following described protocols [67, 68]. This represents a total of 12 potential hybridization data per spot. Slides were scanned with the GenePixTM Personal 4100A Microarray Scanner (MDS Analytical Fulvestrant ic50 Technologies Inc., Sunnyvale, CA, USA). Mean hybridization signal and mean local background intensities were determined for each spot of the microarray images

with the GenePix 5.0 software for spot detection, image segmentation and signal quantification (MDS Analytical Technologies Inc., Sunnyvale, CA, USA). The log2 value of the ratio of intensities was determined for each spot according to M i = log2(R i /G i ), being R i = I ch1i – Bgch1i and G i = Ich2i – Bgch2i ; where I ch1i and Ich2i are the signal intensities in channels 1 and 2, respectively, and Bgch1i and Bgch2i are the background intensities of each spot in channels 1 and 2, respectively. The mean intensity (A i ) was calculated for each spot using the formula: A i = log2(R i G i )0.5 [67]. Normalization and t-statistics were carried out with the EMMA 2.8.2 software developed at the Bioinformatics Phospholipase D1 Resource Facility, Center for Biotechnology (CeBiTec), Bielefeld University (https://​www.​cebitec.​uni-bielefeld.​de/​groups/​brf/​software/​emma/​cgi-bin/​emma2.​cgi[69]) which implements a normalization method based on local regression accounting for intensity and spatial dependence in dye biases [70]. Genes were scored as differentially expressed if the confidence indicator P was ≤ 0.05, the mean intensity A ≥ 8 and the expression ratio M ≥ 1 or ≤ -1, as calculated from at least eight of the 12 replicates per spot. Proteomics Preparation of protein extracts and 2D-gel electrophoresis were carried out essentially as described previously [71]. The S. meliloti wild-type 2011 and derivative strains 2011-1.

05) both in vitro and in vivo. Figure 5 Expression of Bcl-2 and Bax as detected by immunohistochemistry. Detection of the expression of apoptosis-related proteins of Bcl-2 and Bax showed that ChA21 therapy could upregulate the expression of Bax and downregulate the expression of Bcl-2 in vitro and in vivo. Figure 6 The MOD values on expression of Bcl-2 and Bax. MOD values of Bax in ChA21 treatment group were higher than those in the control group (P < 0.05), while MOD values of Bcl-2 and the ratio of Bcl-2 to Bax were lower (P < 0.05) both in vitro and in vivo. (magnification: in vitro × 400; in vivo × 200). Discussion www.selleckchem.com/products/chir-99021-ct99021-hcl.html In recent years, a number of monoclonal antibodies

(MAb) have been developed against HER-2 ECD, such as 4D5 (Herceptin, trastuzumab) and 2C4 (Pertuzumab) [10, 23]. Herceptin is a humanized recombinant MAb that

was first approved by the U.S. FDA for use in HER-2 over-expressing metastatic breast cancer. Current studies show that it appears to be a candidate as a treatment modality for HER-2 over-expressing ovarian cancer as well Obeticholic Acid chemical structure [24]. However, more studies in clinical application showed that there is an increased incidence of serious cardiac events, particularly when Herceptin was administered in combination with anthracyclines [25, 26], and pulmonary complications also had been reported [27]. Patients who have had a significant therapeutic effect for a time by Herceptin treatment started to appear the drug resistant [28, 29]. Moreover, according to the surveyed data about the clinical therapeutic effect of Herceptin, the therapeutic effective rate of Herceptin treated alone to

patients with HER-2 over-expressed only reached 12-14% [30]. These results urge people to conduct more researches, regarding the mechanism of antibodies curing the neoplasms, and develop novel humanized recombinant MAb for HER-2. Therefore, three strains of murine MAb A18, A21, and A22, which direct against HER-2 ECD were developed, and MAb A21 was found to specifically inhibit the growth of HER-2 over-expressing cells [20]. To reduce the potential for generating a human anti-mouse immune response, Murine MAb A21 was humanized Digestive enzyme to develop an anti-HER-2 engineering antidbody, ChA21 [16, 17]. In previous study, we constructed a molecular model of Ag-Ab complex based on the crystal structures of the ChA21 scFv and HER-2 ECD [18]. Unlike Herceptin that binds to subdomain IV, ChA21 recognizes epitopes that are mainly located in subdomain I. It is possible, that anti-HER-2 antibodies targeting distinct epitopes have different biological functions on cancer cells with different mechanisms [31]. Thus, in the present study, we confirmed that ChA21 binding to subdomain I could inhibit the growth and induce apoptosis of HER-2 over-expressing human ovarian cancer cells SK-OV-3 in vitro and in vivo. The results showed that in vitro, the cell growth was significantly inhibited by ChA21 in a dose- and time-dependent manner.

All authors read and approved the final manuscript.”
“Background In recent

decades, there has been a great interest in the application of thermoelectric (TE) effects in alternative clean energy sources [1–6]. For the evaluation of the thermoelectric performances of TE devices, their efficiencies BKM120 order can usually be quantified by a dimensionless figure of merit (ZT), S 2 σT/κ or a power factor S 2 σ, where S is the Seebeck coefficient, σ is the electrical conductivity, κ is the thermal conductivity, and T is the absolute temperature. High-performance thermoelectric materials with high ZT values should have a large Seebeck coefficient, high electrical conductivity, and low thermal conductivity [2, 7, 8]. To obtain an efficiently comparable to a household refrigerator, a ZT value at least 3 is desired for more widespread applications [6]. Recently, several researchers have alternatively studied two-dimensional (2D) thin films [9, 10] to overcome the limitations of 1D nanostructured materials whose thermal properties buy Navitoclax are highly dependent on their dimensionality

and morphology [3, 11–13]. In 2010, Tang et al. reported that the thermal conductivity of holey Si thin film consistently reduces by around 2 orders of magnitude with a reduction in the pitch of the hexagonal holey pattern down to approximately 55 nm with approximately 35% porosity [9]. Similarly, Yu et al. reported that a Si nanomesh structure exhibits a substantially lower thermal conductivity than an equivalently prepared array of Si nanowires [10]. Hence, we believe that the 2D materials (i.e., thin film formation) could be highly promising candidates as TE materials for scalable and practical TE device applications. Magnetite

aminophylline (Fe3O4) is a well-known half-metallic material, whose electronic density of states is 100% spin polarized at the Fermi level [14, 15]. These properties allow Fe3O4 to be a promising candidate for spintronic devices [16]. However, the thermal property of this metal compound has not been widely studied. In 1962, Slack extensively studied and analyzed the thermal conductivity of a single crystal of paramagnetic bulk Fe3O4 materials at temperatures of 3 to 300 K [17]. He found that the thermal conductivity of Fe3O4 falls sharply with increasing temperature at the approximately 121 ± 2 K transition and reported a notable effect of vacancy and impurities on Fe3O4, particularly below 30 K. The thermal conductivity of pure Fe3O4 was as low as approximately 6 W/m · K at 300 K, owing to phonon scattering by local disorder in the materials, thus implying that pure Fe3O4 is a promising TE material. To the best of our knowledge, there have been no studies on the thermal properties of Fe3O4 thin films.

coli BL21. Growth temperature were 37°C, except where indicated and growth rates were estimated by measuring the increase in OD600. Origin of the immunoreactive MS2/28 DNA fragment Isolation and characterization of the M. synoviae DNA fragment MS2/28 [GenBank: MSU66315] was previously described [18]. MS2/28 contains two partial ORFs, referred to as MS2/28.1 (5′ end) and MS2/28.2 (3′ end). Reverse transcription and polymerase chain reaction (RT-PCR) The total RNA of M. synoviae strain WVU 1853 was isolated from a

24-h culture, using a protocol recommended for Gram-positive bacteria [23]. Genomic M. synoviae DNA was eliminated from the RNA preparation using DNAse I (2,5 mg/ml) digestion for a 1-h period at 37°C. DNAse I-treated https://www.selleckchem.com/products/cx-4945-silmitasertib.html total RNA of M. synoviae was prepared as described above. Reverse transcription was performed at 55°C in a 20 μl reaction mixture containing 2 μg of total RNA, 4 μl of dNTP at 20 mM each, 12.5 μM of the reverse primer 2/28.1Rev (5′-GGGCGGCCGCCTACACTTGCAGTACTTGGCG-3′), 20 units of AMV reverse transcriptase and 2 μl of 10 × buffer reaction (50 mM Tris-Cl, 8 mM MgCl2, 30 mM KCl, 1 mM dithiotreitol, pH = 8). The first strand cDNA synthesis was allowed to proceed

for 1 h followed by inactivation at 65°C during 10 min. PCR amplification was next performed using 2/28.1Rev coupled to the PromF primer (5′-GTCGACGAAATTAAGTAAATTATTAAAG-3′) which anneals to the 5′ end region (-120 to -98) of the expected vlhA1-derived transcript. The amplification A-769662 mw reaction consisted of 30 cycles of 94°C for 120 s, 55°C for 120 s and 72°C for 120 s, followed by an extension of 72°C for 7 min. Cloning and sequencing of the RT-PCR

product The 1.934 kb RT-PCR product was purified and ligated into NotI/SalI-digested pBluescript II KS+ plasmid. The ligation product was used to transform E. coli HB101 cells and recombinant clones were screened using restriction analysis. Determination Bupivacaine of the nucleotide sequence was performed with the Prism Ready Reaction Dye Deoxy Terminator Cycle sequencing Kit on an ABI PRISM 377 DNA sequencer (Applied Biosystems). The cloned amplicon was sequenced in both orientations from two different plasmid clones using sequence-specific internal and plasmid-anchored primers. The sequence data were edited and aligned using the software programs BioEdit [24] and ClustalW [25]. Confirmation of the position of the completed MS2/28.1 gene sequence relative to the unique vlhA1 promoter Using genomic DNA extracted from single colonies as template, PCR amplifications were performed, combining EXpro (5′-CAAATTTAGTTAATTCACTTA-3′), a sense primer placed in the vlhA1 promoter region (-213 to -193), with either vlhA1 R (5′-TATTGTTTTCGGCATTATTTGCTACGTC-3′), a vlhA1-specific reverse primer, or ORF5.1R (5′-GCCTCCACTTCCATCTCCGCTTTCACT-3′), the MS2/28.1-specific reverse primer. To ensure that the full-length MS2/28.

In the specific case of EBA opportunities, we

assume that we can identify and conserve natural ecosystems that will improve resilience of both ecological and human communities even though this assumption is currently being debated (Feagin et al. 2010). In addition, using this approach assumes that we have sufficient knowledge to determine which ecosystems and communities are most vulnerable and what combination and placement of conservation areas will deliver the greatest benefits Caspase inhibitor clinical trial to both communities. Finally, some EBA strategies are dependent upon the provision of specific ecosystem services, yet the study and valuation of such services remains an emerging science (Kareiva et al. 2010). Trade-offs Trying to achieve conservation outcomes through alliances with activities not principally directed at conservation involves many trade-offs. By their very nature, these emerging opportunities are unlikely to be outright win–win situations for conservation because they include objectives in addition to those that are specific to biodiversity conservation (Venter et al. 2009). Consequently, CT99021 mouse conservation planners, scientists, and practitioners may have to be willing to compromise on conservation objectives in pursuit of these opportunities. Emerging opportunities may be accompanied

by emerging challenges, such as new industries and sectors (e.g., biofuels; Fargione et al. 2009) arising in response to a changing climate that pose novel or additional impacts to biodiversity. These emerging opportunities and challenges could also be incorporated into the

menu of opportunities and constraints. Data considerations Each of the approaches to climate change adaptation in systematic conservation planning may require the collection and inclusion of additional data sets (Table 1). These data sets are additional to, not in place of, data on the distribution of biodiversity, as well as on the opportunities and constraints on conservation action, which are required for all regional assessments. Thymidylate synthase Future climate change projections can be readily explored and obtained from various sources, such as the Climate Wizard tool (Girvetz et al. 2009), but additional data, information and analyses are needed to conduct climate change impact or vulnerability analyses (IPCC 2007b; Ferdaña et al. 2010; Game et al. 2010; Glick and Stein 2010). Table 1 Additional data for regional conservation assessments that may be needed to support the climate change adaptation approaches described in this document Adaptation approach Additional data needed for regional assessments Conserving the geophysical stage Distribution of geophysical and topographic properties (e.g.

The results obtained indicate a good correspondence between the two methods (Table 2). These results suggest that the sensitivity reached for this procedure allow determining very low level of B. cinerea antigens in apparently healthy fruit that can deteriorate suddenly due to the development of latent or quiescent infection into visible disease. Also, the DNA quantified by the method developed

by González et al. [33] from uninfected and infected fruit extracts samples was amplified by PCR, with the purpose of verify if the same correspond to specific DNA of B. PLX4032 clinical trial cinerea [34]. The Figure 3A shows the DNA-B. cinerea from infected fruit extracts samples (apples, table grapes and pears respectively). The bands observed in the lane 1 correspond to a standard of molecular weight marker (MW); in the lanes 2, 3 and 4 correspond to a molecular marker (IGS) for each fruit extracts; in the lanes 5, 6 and 7 correspond to the Boty transposable element for each fruit extract and in the lanes 8, 9 and 10 correspond to the Flipper transposable element for each fruit extract. The Figure 3B shows control extracts made from uninfected fruits. There, only were observed bands in the lane 1 which correspond to a standard of molecular weight marker (MW) indicating clearly the absence of B. cinerea. Figure 3 Gels show one

sample of each kind of infected fruit extract with conidial suspensions (1 × 10 5 spores mL -1 ) and a control per each kind of uninfected fruit extract sample. (A) PCR product analysis of infected fruit extracts samples. Lane 1: standard molecular weight marker (MW). Lanes 2, 3 and 4: molecular marker IGS (ribosomal intergenic

C59 wnt spacer). Lanes 5, 6 and 7: Boty transposable element. Lanes 8, 9 and 10: Flipper transposable element. (B) PCR product analysis of uninfected fruit extracts samples. Lane 1: standard molecular weight marker (MW). Lanes 2, 3, 4, 5, 6, 7, 8, 9 and 10: not observed any bands, indicating clearly the absence of B. cinerea. The presence of both transposable elements (Boty and Flipper) indicates that B. cinerea can be molecularly out characterized as subpoblation transposa-type [35, 36]. Conclusions In the present study, a specific and sensitive indirect competitive ELISA for the quantification of B. cinerea in commercial apple, table grape and pear samples was developed and validated. This inexpensive and simplified method can be applied for 96 fruit samples, per each microtiter plate with a total time for the assay of 35 min. Preparations of immobilized antigen on surface microtiter plates were perfectly stable for at least 4 months assuring the reproducibility of the assay. This is one important advantage for the possible commercialization of the developed ELISA. The results obtained suggest that the sensitivity reached for this procedure allows determining very low levels of B. cinerea antigens in apparently healthy fruits.

Recently it has been shown that XylS dimers bind to DNA sequentially. The first monomer to bind is the one proximal to the RNAP binding site. This leads to [10DNA bending, which in turn enables the second monomer to bind, and indicates that XylS is dimerized prior to DNA binding [16]. At typical cell-internal XylS-levels only 30-40% of the Pm promoter sequences are occupied in vitro and it has been proposed that complete occupancy cannot be achieved by XylS amounts which do not exceed its CHIR 99021 intracellular solubility [21]. Vectors which

combine the XylS/Pm expression system with the broad-host-range mini-RK2 replicon [22, 23], in which XylS is expressed from

its natural Ps2 promoter, have been shown to be capable of producing recombinant proteins at industrial levels in Escherichia coli[24, 25]. Expression levels of these vectors could be heavily increased by mutating different Bortezomib cell line DNA control elements of the expression cassette [10, 26, 27], and recently it has been demonstrated that they could be yet further improved when mutated DNA elements were combined [28]. When induced expression levels are increased it leads, in most cases, to undesired high expression levels also in the absence of inducer. For the XylS/Pm expression system the background expression could be strongly reduced when the 5′-UTR flanking the Shine-Dalgarno site was mutagenized and this has been demonstrated to be useful for metabolic engineering purposes [29]. With this approach an induction ratio of 260-fold could be reached, however, as a consequence induced expression levels were also reduced for these constructs. A possible alternative method of reducing uninduced expression could be to regulate the XylS expression level. Previous experiments have shown that strong XylS overexpression, as for example from the bacteriophage

T7 promoter or from Ps1, results in a complete loss of inducibility [21, 30]. Fusion of xylS to the Psal promoter, which can be activated by similar inducers as Pm, allowed simultaneous acetylcholine induction of XylS expression and XylS activation. Induction ratios that could be reached by this approach were about 180- to 240-fold [31]. Here we report a more detailed study on the relationship between XylS expression levels and expression levels achieved from the Pm promoter, both under induced and uninduced conditions. Based on the outcomes of this study we propose a model that aims to explain the behaviour of XylS as a function of its concentration and its formation of monomers, dimers and higher order oligomers.

It makes Φ rt move to the right in energy to appear in the photovoltage spectra as Φ 0. Two processes can be mixed in this conditions, band-to-band transition with separation of electron-hole Pritelivir pairs and electron injection into the silicide over the potential barrier, both generating photo-emf. In addition, a reduction of n may increase barriers at the interface [25, 26]; a usual Ni silicide barrier (around 0.7 eV) may be completely restored at some domains or be still reduced (around 0.5 eV) at different places. Hole injection into the silicide

layer from polysilicon grain boundaries may become more probable over reduced barriers to holes. This statement finds confirmation in the spectra plotted in Figure 5 which have been obtained under irradiation of a diode by a wide-band IR radiation of a tungsten bulb filtered by a polished Si wafer (h ν

on the sample, the stronger the curves bow in the high-energy part of the graph and the lesser values of the photo-emf are detected. It may be caused by injection of holes from potential wells at grain boundaries Rapamycin of poly-Si into the silicide film because of additional wide-band IR lighting of the sample resulting in charge reduction of both the silicide and polysilicon layers. Figure 5 Photovoltage spectra obtained at 80 K. The diode is irradiated by the light of a tungsten lamp through a Si filter. The power density of light with h νcAMP are guides to the eye. Thus, a set of competing processes becomes possible at 80 K. Non-uniformity of the spatial potential throughout the Ni silicide/poly-Si interface may locally act in favor of one of these competing processes. As a consequence, the impact of several barriers is observed in the photoresponse

spectra in the order of magnitude of contribution of processes associated with them to the resultant photo-emf in different spectral ranges. Investigating the temperature dependences of the I-V characteristics close and above the room temperature, we have found the thermal sensitivity of the diodes to be sufficiently high to consider them as potential elements of uncooled bolometers. Figure 6a,b demonstrates temperature dependences of the forward and reverse currents of the diodes (I), respectively, for fixed (and stabilized) voltages (U). Temperature coefficient of the sensor current TCS =d[ lnS(T)]/d T, where S=I, derived from the graphs presented in Figure 6a,b as a function of bias voltage (Figure 6c) varies from −0.3%/℃ to −0.6%/℃ for the forward bias and remains nearly constant around 2.5 %/℃ for the reverse bias. Notice that at small values of the forward bias, TCS is positive but rapidly drops with the growth of the absolute bias and equals 0 at U≈−1 V.

BLB, LMY, LLH, BK and CMM were co-authors, assisting with data analysis. All authors have read and approved the final manuscript.”
“Introduction

Sports nutrition professionals need to know how to evaluate the scientific merit BAY 73-4506 clinical trial of articles and advertisements about exercise and nutrition products so they can separate marketing hype from scientifically-based training and nutritional practices. In order to help ISSN members keep informed about the latest in sports nutrition, we have updated the ISSN Exercise & Sports Nutrition Review that was used to help launch the JISSN (originally called the Sports Nutrition Review Journal). This paper provides an overview of: 1.) The definitional category of ergogenic aids and dietary supplements; 2.) How dietary supplements are legally regulated; 3.) How to evaluate the scientific merit of nutritional supplements; 4.) General nutritional strategies to optimize performance and enhance recovery; and, 5.) An overview of our current understanding of the ergogenic Ibrutinib cell line value in regards to weight gain, weight loss, and performance enhancement supplements. We have also categorized nutritional supplements into ‘apparently effective’, ‘possibly

effective’, ‘too early to tell’, and ‘apparently ineffective’ as well a description of our general approach into educating athletes about sports nutrition. Over the last five years there have been many changes to our original categorization of supplements. In addition, a number of new supplements have been introduced to the market are reviewed in this article. While some may not agree with all of our interpretations of the literature and/or categorization of a particular supplement,

and some classifications may change over time as more research is forthcoming, these interpretations are based on current available scientific evidence and have been well received within the broader scientific Bcl-w community. Our hope is that ISSN members find this information useful in their daily practice and consultation with their clients. Ergogenic Aid An ergogenic aid is any training technique, mechanical device, nutritional practice, pharmacological method, or psychological technique that can improve exercise performance capacity and/or enhance training adaptations [1–3]. This includes aids that may help prepare an individual to exercise, improve the efficiency of exercise, and/or enhance recovery from exercise. Ergogenic aids may also allow an individual to tolerate heavy training to a greater degree by helping them recover faster or help them stay injury-free and/or healthy during intense training. Although this definition seems rather straightforward, there is considerable debate regarding the ergogenic value of various nutritional supplements.

Int

J Infect Dis 2009, 13:547–551.PubMedCrossRef 13. Whipp MJ, Davis JM, Lum G, de Boer J, Zhou Y, BTK inhibition Bearden SW, Petersen JM, Chu MC, Hogg G: Characterization of a novicida -like subspecies of Francisella tularensis isolated in Australia. J Med Microbiol 2003, 52:839–842.PubMedCrossRef 14. Birdsell DN, Stewart T, Vogler AJ, Lawaczeck E, Diggs A, Sylvester TL, Buchhagen JL, Auerbach RK, Keim P, Wagner DM: Francisella tularensis subsp. novicida isolated from a human in Arizona. BMC Res Notes 2009, 2:223.PubMedCrossRef 15. Vogler AJ, Birdsell D, Price LB, Bowers JR, Beckstrom-Sternberg SM, Auerbach RK, Beckstrom-Sternberg JS, Johansson A, Clare A, Buchhagen JL, Petersen JM, Pearson T, Vaissaire J, Dempsey MP, Foxall P, Engelthaler DM, Wagner DM, Keim P: Phylogeography of Francisella

tularensis : global expansion of a highly fit clone. J Bacteriol 2009, Temsirolimus cell line 191:2474–2484.PubMedCrossRef 16. Svensson K, Granberg M, Karlsson L, Neubauerova V, Forsman M, Johansson A: A real-time PCR array for hierarchical identification of Francisella isolates. PLoS One 2009, 4:e8360.PubMedCrossRef 17. Pilo P, Johansson A, Frey J: Identification of Francisella tularensis cluster in central and western Europe. Emerg Infect Dis 2009, 15:2049–2051.PubMedCrossRef 18. Vogler AJ, Birdsell DN, Lee J, Vaissaire J, Doujet CL, Lapalus M, Wagner DM, Keim P: Phylogeography of Francisella tularensis ssp. holarctica in France. Letters in Applied Microbiology 2010, 52:177–180.CrossRef 19. Johansson A, Berglund L, Eriksson U, Göransson I, Wollin R, Forsman M, Tärnvik A, Sjöstedt A: Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 2000, 38:22–26.PubMed 20. Egorova LS, Il’in VA, Algazin IP, Mal’kov GB: [Isolation of the causative agent

of tularemia from Siberian lemmings in Eastern Taymyr]. Zh Mikrobiol Epidemiol Immunobiol 1975, 128–132. 21. Zhang F, Liu W, Chu MC, He J, Duan Q, Wu XM, Zhang PH, Zhao QM, Yang H, Xin ZT, Cao WC: Francisella tularensis Erastin in rodents, China. Emerg Infect Dis 2006, 12:994–996.PubMed 22. Vodop’ianov AS, Mishan’kin BN, Pavlovich NV, Pichurina NL: [Genotypic heterogeneity and geographic diversity of collection strains of Francisella tularensis as determined using the VNTR variability analysis and DNA sequencing]. Mol Gen Mikrobiol Virusol 2007, 33–40. 23. Zhang F, Liu W, Wu XM, Xin ZT, Zhao QM, Yang H, Cao WC: Detection of Francisella tularensis in ticks and identification of their genotypes using multiple-locus variable-number tandem repeat analysis. BMC Microbiol 2008, 8:152.PubMedCrossRef 24. Keim P, Van Ert MN, Pearson T, Vogler AJ, Huynh LY, Wagner DM: Anthrax molecular epidemiology and forensics: using the appropriate marker for different evolutionary scales. Infect Genet Evol 2004, 4:205–213.PubMedCrossRef 25.